Diagnostics

Category VIEW ALL

chevron_right

Accelerate Blue Foundry - 2025 (57)

chevron_right

Agricultural, Food Science and Nutrition (1)

chevron_right

chevron_right

chevron_right

Chemical Processes and Synthesis (21)

chevron_right

chevron_right

Diagnostics (50)

chevron_right

Digital Health (10)

chevron_right

Energy, Infrastructure and Environment (4)

chevron_right

chevron_right

Manufacturing Process (23)

chevron_right

chevron_right

Medical Devices (115)

chevron_right

Research Tools and Reagents (174)

chevron_right

Therapeutics and Vaccines (86)

chevron_right

chevron_right

Semiconductor, MEMS, and Electronics (85)

chevron_right

Recorded and Creative Works (0)

chevron_right

MOSS - Michigan Open Source Support (60)

chevron_right

Translational Science Training Resources (11)

chevron_right

Nursing Innovation (20)

Iris and LZGD: Massively Parallel GPU-based Compression Mechanism

Technology No. 2023-293

Diagnostic Peptides for Early Cancer Detection

Technology No. 2023-328

ChiroFlux: A Novel Platform for Rapid, Marker-Agnostic Extracellular Vesicle Capture for Clinical and Research Applications

Technology No. 2025-532

12-HETE as a Diagnostic Tool for Early Detection of Cardiovascular and Thrombotic Risk (Accelerate Blue)

Technology No. 2021-106

Tissue-Based Biomarker for Kidney Cancer

Technology No. 2022-046

TEWL Device for Monitoring of Severe Allergic Reactions

Technology No. 2023-240

Generative AI Summarization for Dynamic Tracking of Clinical Symptoms (Accelerate Blue)

Technology No. 2024-382

Meningioma ExoChip

Technology No. 2025-126

Microneedle Array for in-vivo Cancer Monitoring via Cancer Exosome Isolation

Technology No. 2023-102

Using Oxygen Perfusion as a Biomarker for traumatic Brain Injury

Technology No. 2023-232

Automated Segmentation and Severity Analysis of Liver Parenchymal Disruption

Technology No. 2021-290

Iris Whole Slide Imaging -- Rapid Tile Buffering

Technology No. 2022-199

Monitoring Response to Immunotherapy

Technology No. 2022-265

Generative AI Summarization for Dynamic Tracking of Clinical Symptoms

Technology No. 2024-382

Spatial Relationship of Immune and Epithelial Cells to Diagnose, Prognosticate and Predict Treatment Efficacy

Technology No. 2021-063

Evaluation of Cell-Extracellular Vesicle Interaction using Novel Microfluidic Microsystem (CellExoChip)

Technology No. 2022-134

Risk Factors of Fibromuscular Dysplasia and Related Dysplasia-Associated Arterial Diseases

Technology No. 2022-233

Soluble Urokinase Plasminogen Activator Receptor (SuPAR) as a Therapeutic Target for Prevention and Treatment of Atherosclerosis

Technology No. 2021-428

Protein Biomarkers for Detection and Prediction of Cytokine Release Syndrome and Neurotoxicity during CAR T Cell Therapy

Technology No. 2021-417

Acetylcarnitine (C2) as a Biomarker for a Mortality Benefit from Supplemental L-carnitine in Patients with Septic Shock

Technology No. 2020-390

Digital Protein Biomarker Array for Multiplex Immunoassays

Technology No. 2019-323

Novel Blood Test to Predict Safe Foods for Infants and Toddlers with Food Protein-Induced Enterocolitis Syndrome (FPIES)

Technology No. 2019-143

Impeded Diffusion Fraction for Quantitative Imaging Diagnostic Assay

Technology No. 2021-130

Point-of-Care Blood Biomarker Analysis System

Technology No. 2019-118

Use of Soluble Urokinase Plasminogen Activator Receptor Levels in the Management of Patients with Cardiovascular Disease

Technology No. 2019-155

Methods to quantify metabolic activity in human tissues

Technology No. 2023-133

Methods to be Used in Conjunction with Biomarker Ratio Imaging Microscopy

Technology No. 2019-182

Spatial Patterns of Phosphofructokinase Isotypes within Ductal Carcinoma in Situ Lesions Accurately Predict Cancer Recurrences

Technology No. 2021-431

Retention Time Trajectory Matching for Peak Identification in Chromatographic Analysis

Technology No. 2021-241

Epithelial-Mesenchymal Transition-based Gene Expression Signature for Kidney Cancer

Technology No. 2022-045

12-HETE as a Diagnostic Tool for Early Detection of Cardiovascular and Thrombotic Risk

Technology No. 2021-106

Modified Tissue Factor with Increased Clotting Activity

Technology No. 2022-294

Detection of CDK12 Alterations to Predict Prostate Cancer Therapeutic Sensitivity

Technology No. 2018-260

Understanding Lineage Plasticity Risk in Lethal Prostate Cancer

Technology No. 2022-131

Transepidermal Water Loss as an Anaphylaxis Monitoring Tool

Technology No. 2022-036

Intercellular Junction Proteins and Food Allergy

Technology No. 2020-239

Genetic Factors Influencing SCAD Risk

Technology No. 2020-231

A Non-Contact System and Method for Patient Motion Monitoring

Technology No. 2019-074

Microfluidic Flow Control using Direct-Current Peristaltic Pump

Technology No. 2020-236

Markers of L-Carnitine Drug Response in Patients with Sepsis

Technology No. 6190

Peptide Ligand Specific for CD44

Technology No. 2021-454

Tissue Factor Immunothromobotic Marker for COVID-19 and other Inflammatory Diseases

Technology No. 2021-089

Chiroptical Detection and Mutation Analysis of Cancer-Associated Extracellular Vesicles in Microfluidic Devices

Technology No. 2021-455

Polydiacetylene Liposome Microarray toward Facile Measurement of Platelet Activation in Whole Blood

Technology No. 2022-020

Oral Hygiene Plaque Control Heat Map

Technology No. 2020-439

Method for Catalytic Glycosylation

Technology No. 2019-237

Abiraterone Analog for Prostate Cancer with Reduced Side Effects

Technology No. 2019-198

Peptide Specific for Fibroblast Growth Factor Receptor 2 for Detection and Therapy of Gastrointestinal Adenocarcinomas

Technology No. 7309

Peptide Ligand Specific for c-Met

Technology No. 2019-013

An Orientation-Independent Order Parameter Derived from Magnetic Resonance R1rho Dispersion in Ordered Tissue

Technology No. 2019-280